Opaleye Management Inc. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$6,979,000
-7.2%
205,3810.0%1.30%
+4.4%
Q2 2021$7,519,000
-24.5%
205,381
-7.5%
1.25%
-14.6%
Q1 2021$9,954,000
-21.4%
222,0000.0%1.46%
-11.7%
Q4 2020$12,670,000
+11.2%
222,0000.0%1.66%
-25.7%
Q3 2020$11,389,000
-12.9%
222,0000.0%2.23%
-15.7%
Q2 2020$13,081,000
+43.1%
222,0000.0%2.64%
+9.1%
Q1 2020$9,140,000
-34.6%
222,000
-1.1%
2.42%
-11.7%
Q4 2019$13,973,000
+79.0%
224,500
-2.4%
2.74%
-2.9%
Q3 2019$7,806,000
+11.7%
230,000
-25.8%
2.82%
+32.5%
Q2 2019$6,991,000
-11.4%
310,000
-8.8%
2.13%
-2.5%
Q1 2019$7,891,000
+10.6%
340,0000.0%2.18%
-17.9%
Q4 2018$7,136,000
-56.1%
340,000
-19.0%
2.66%
-35.6%
Q3 2018$16,262,000
-1.6%
420,0000.0%4.14%
-3.3%
Q2 2018$16,527,000
+126.0%
420,000
+15.1%
4.28%
+104.6%
Q1 2018$7,314,000
+77.5%
365,000
+68.2%
2.09%
+43.5%
Q3 2017$4,120,000217,0001.46%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders